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13% during the first half year of hemodialysis in a stable cohort.Rise in serum albumin and creatinine in the first half year on
The slope of serum albumin versus time predicted survival,hemodialysis.
but it was not as predictive as the absolute albumin concentra-Background. Serum albumin and creatinine have been re-
tion. The pattern of correlations of baseline urinary proteinported to rise in new hemodialysis patients; however, these
and creatinine excretion with the respective monthly serumtrends have not been quantitated in a stable cohort, and their
values of albumin and creatinine and their slopes is consistentdeterminants and prognostic value are unknown.
with the hypothesis that as residual renal function declines,Methods. This study examined the changes in monthly val-
ues of serum albumin and creatinine over the first half year of progressive retention of protein and creatinine contributes to
hemodialysis in 115 patients who survived to the start of the the respective rises in serum albumin and creatinine.
sixth month. After verifying that the trends were approximately
linear, we calculated the rates of rise (slope) of six predialysis
values of serum albumin (months 1 through 6) and of creatinine
The strongest predictors of survival in hemodialysis(months 2 through 7) and examined their associations with age,
patients are the serum levels of albumin and creatinine,diabetes, race, baseline 24-hour urine protein and creatinine
excretion, and survival during the latter half of the first year. traditional measures of visceral and somatic protein sta-
Results. Serum albumin rose by 13% over months 1 through tus [1–3]. Although intercorrelated, serum albumin and
6 [0.08 6 0.12 (sd) g/dl/month, P , 1029 vs. zero slope]. Patients
creatinine predict survival independently of each otherwho survived the entire year had higher mean values for both
and of other important predictors such as dialysis doseserum albumin (month 1, P , 0.003; months 3 through 6, P ,
1023) and rate of rise of albumin (0.09 6 0.11 g/dl/month vs. [1–5]. These associations may be causal if protein stores
0.01 6 0.13 g/dl/month, P , 0.005) than patients who died directly contribute to survival in uremia, a catabolic mi-
during months 6 through 12, but the slope was not an indepen- lieu [6–9], or they may be due to confounding, if reduced
dent predictor of survival after adjusting for serum albumin
protein stores simply reflect the intensity and cumulativeconcentration. Baseline proteinuria correlated inversely with
effect of prior catabolic insults that promote mortalityserum albumin measured at the first and second months (P ,
0.005) and directly with the albumin slope (r 5 0.49, P , 1025). through pathways other than protein malnutrition [3].
Serum creatinine rose by 12% between months 2 through 7 The “natural history” of serum albumin and creatinine
(0.12 6 0.47 mg/dl/month, P , 0.02). Survivors had a signifi- appears to differ in new versus long-standing patients
cantly higher mean baseline creatinine excretion (P , 0.03)
(abstracts; Jadoul et al, J Am Soc Nephrol 9:212A, 1998;and serum creatinine (month 2, P , 0.03; months 3 through
Kloppenburg et al, J Am Soc Nephrol 8:198A, 1997)7, P , 0.01) but only a marginally higher rate of rise of serum
creatinine (0.16 6 0.47 mg/dl/month vs. 20.07 6 0.48 mg/dl/ [10–16]. In long-standing hemodialysis patients with neg-
month, P , 0.06) than patients who died during the second half ligible renal function, serum albumin and creatinine lev-
of the year. Baseline urinary creatinine excretion correlated els have been reported to decline slowly over time (ab-directly with serum creatinine at month 2 (P , 0.01) and more
stract; Jadoul et al, op. cit.) [10, 15]. One stable cohortstrongly at months 3 through 7 (P , 1023), as well as correlating
monitored for four years experienced small but signifi-with the creatinine slope (r 5 0.26, P , 0.03).
Conclusions. Serum albumin and creatinine rose by 12 to cant declines in both serum albumin (20.005 g/dl/month)
and creatinine (20.065 mg/dl/month) at rates faster than
could be attributed to aging [10]. A similar rate of decline
Key words: residual renal mass function, mortality and dialysis, survival
for serum albumin (approximately 20.0065 g/dl/month)and HD, urinary protein excretion, protein status, predictors of sur-
vival. was observed by Locatelli et al in a two-year study of a
stable cohort receiving adequate hemodialysis [15].Received for publication April 8, 1999
On the other hand, new dialysis patients appear toand in revised form July 15, 1999
Accepted for publication July 19, 1999 experience a progressive rise in both serum creatinine
and albumin [4, 12–14]. Parker et al first reported that 1999 by the International Society of Nephrology
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mean serum albumin rose by approximately 0.3 g/dl in betes, and race (factors also known to influence serum
creatinine and/or albumin [2]); and (c) test whether thethe first six months on hemodialysis in a population un-
dergoing attrition [14], and this finding was confirmed rates of change in serum albumin and/or creatinine corre-
late with subsequent survival, and if so, whether theyin another cohort undergoing attrition, which also mani-
fested a rise in mean serum creatinine of approximately are independent predictors.
0.9 mg/dl [4]. These reported rates probably overesti-
mate the true rise to be expected in individual patients,
METHODS
as patients with low serum albumin and creatinine values
Patient selection and clinical dataare more likely to die, and the loss of such patients from
the group results in an increase in the mean values [17]. The population eligible for study was the 195 patients
who started maintenance hemodialysis at the BrooklynParker et al nonetheless confirmed that a true rise occurs
for serum albumin by examining subsets of patients with VA Medical Center between April 1992 and April 1997
[mean age, 65 6 12 (sd) years; composition, 60% Africanpaired data at various time points [14].
Although the cause of the rise in creatinine in new American, 36% Caucasian, and 4% Hispanic; proportion
with diabetes mellitus, 47%). The criteria for inclusionhemodialysis patients is presumably the known progres-
sive decline of residual kidney function [12, 18, 19], as in the study cohort were survival through the first six
routine monthly blood samplings (that is, to the start ofwell as, perhaps, an increased intake of creatine and
protein [20], the determinants of the rise in serum albu- the sixth month), available albumin values for at least
four of the six samplings, including the sixth, and com-min in new hemodialysis patients are unknown. Logi-
cally, the rise in albumin concentration must be due to plete follow-up to death or censorship at the end of the
first year on hemodialysis. Ultimately, 114 men and 1some combination of (a) increased rate of synthesis, (b)
decreased rates of loss and catabolism, (c) hemoconcen- woman were included in the cohort. No patient was
transferred to peritoneal dialysis or received a transplanttration, and/or (d) lower transcapillary escape. Although
an increased rate of albumin synthesis caused by modifi- during the follow-up period. Ninety-four patients sur-
vived to the end of the first year (“survivors”), and 21cation of various factors (inflammatory state [9, 21–24],
dietary protein intake [23], and acidosis [25]) might be died (18%) during the follow-up period, months 6 to 12
(“nonsurvivors”).induced when dialysis is initiated, there is surprisingly
little direct evidence for this supposition. The levels of The mean age of the cohort was 63 6 12 years. The
cohort was 69% African American, 25% Caucasian, andinflammatory markers are unlikely to decrease after an
initiation of dialysis [26–29], and increasing dietary pro- 6% Hispanic, and diabetes was present in 43% of cases.
The causes of ESRD were hypertensive nephrosclerosistein and decreasing acidosis have not been consistently
correlated with serum albumin (abstract; Koppenburg (N 5 40), diabetes mellitus (N 5 49), HIV nephropathy
(N 5 9), diabetes and HIV nephropathy (N 5 1), chronicet al, op. cit.) [18, 21, 24, 30, 31]. Moreover, hemodialysis
is associated with significant amino acid losses [32, 33], glomerulonephritis (N 5 5), obstruction (N 5 2), poly-
cystic kidney disease (N 5 1), multiple myeloma (N 5 1),and an increase in dietary protein intake may lag behind
the initiation of dialysis by months [34]. renal artery stenosis (N 5 1) and unknown (N 5 6).
Sixteen patients started in 1992, 31 in 1993, 19 in 1994,The influence of the dialysis membrane on serum albu-
min has also been studied, with inconsistent results. In 27 in 1995, 14 in 1996, and 8 in 1997.
the study of new patients by Parker et al the six-month
Biochemical datarise in mean albumin was nearly twice as great in patients
dialyzed with a biocompatible membrane as in those Monthly predialysis biochemical data were prospec-
tively recorded in all dialysis patients at the Brooklyndialyzed with cellulose, and mean dry weight rose only
in the biocompatible group [14]. However, the mem- VA Medical Center. Blood was obtained for routine
monthly testing on the first Monday or Tuesday of eachbrane type had no impact at all in the study of long-
standing patients by Locatelli et al [15]. month, except for the sampling before the initial hemodi-
alysis session, which was not necessarily at the beginningWe hypothesized that another heretofore unexamined
cause of the rise in albumin during the initial period of of a month. A multiphasic biochemistry screen was per-
formed using the Ektachem 950 Analyzer (Johnson anddialysis treatment might be the “remission” of nephrotic-
range protein losses as overall renal function progres- Johnson, New Brunswick NJ, USA). Serum albumin was
determined by the bromcresol green method, and serumsively declines [17]. We therefore studied serum albumin
and creatinine during the first six months on hemodialy- creatinine by the creatinine anhydrolase method using
dry slide technology. Of the 115 patients, 98 had six albu-sis in a cohort of stable new patients, in order to: (a)
delineate rates of change unbiased by patient attrition; min measurements. Sixteen had five measurements, and
one had four (mean 5 5.84 measurements per patient).(b) examine whether these rates are influenced by resid-
ual proteinuria and creatinine excretion, or by age, dia- For serum creatinine, the series of six values was begun
Goldwasser et al: Serum albumin and creatinine trends2262
at the second month. Excluded was the first month’s was tested using a simple correlation or multiple linear
regression.value because it did not yet reflect the effect of dialysis
and would obviously be much higher than the second The trends of six monthly measurements of serum
albumin and of serum creatinine were examined in sev-value. Patients were selected who had at least four of
six possible monthly values from the second to seventh eral ways. The mean values of each monthly measure-
ment were calculated for the entire cohort and for sub-samplings; patients without a value for the last sampling
were excluded. Ninety-nine of the 115 patients met these groups by survival status. For those patients with data
at both the first and sixth measurements, the mean per-criteria (81 survivors and 18 nonsurvivors, who died dur-
ing months 7 through 12). Overall, 87 had six measure- centage change over six months was calculated for each
patient as (final value 2 initial value) 4 initial value 3ments, and 12 had five measurements (mean 5 5.88 mea-
surements per patient). These 99 patients did not differ 100%.
Next, we tested if the trends were linear using repeat-significantly in either age (P , 0.44), prevalence of diabe-
tes (P , 0.62), or crude survival (P # 1.0) from the 16 measures analysis of variance (ANOVA). This method
tested the independent effects of time (as a within-patients without serum creatinine values, suggesting no
bias in patient selection. patient factor), survival status (as a between-patient fac-
tor), and their interaction (time 3 survival status) onThe results of the most recent measurement of 24-
hour urine protein and creatinine excretion before the the dependent variable (albumin or creatinine) [35]. The
interaction term tests the hypothesis that the effect ofinitiation of maintenance hemodialysis were retrieved
by searching the hospital’s computerized biochemical time is different in survivors and nonsurvivors. By model-
ing time as a polynomial, this method simultaneouslydatabase for each patient. Twenty-four hour creatinine
excretion was available in 88 patients (71 survivors and tests linear and nonlinear (quadratic and higher power)
effects of time. Because P values are also calculated for17 nonsurvivors); they did not differ from patients with-
out such data in age (P , 0.33), prevalence of diabetes the individual linear and nonlinear effects of time, the
method allows an assessment of whether the trend is(P , 0.19), or crude survival (P , 0.81). Twenty-four
hour protein excretion was available for 80 patients (63 primarily linear or nonlinear. This analysis included only
those patients having a complete set of six measurementssurvivors and 17 nonsurvivors); they did not differ sig-
nificantly in age (P , 0.96), prevalence of diabetes (P , (N 5 98 for albumin, N 5 87 for creatinine).
When the effect of time was shown to be essentially0.17), or crude survival (P , 0.33) from patients without
such data. The urine data are referred to as “baseline” linear, a slope of the trend was next calculated for each
patient (N 5 115 for albumin, N 5 99 for creatinine) bydata, although the median time from the date of urine
collection to the start of dialysis was 51 days, with a applying the least-squares equation for the slope of a
regression line to each patient’s set of four to six valuesrange of 1 to 660 days. The mean creatinine excretion
was 967 6 451 mg, and the median proteinuria was 5.5 g [36].
Finally, the hypothesis that the albumin slope and the(range 0.5 to 52.4 g).
current serum albumin concentration are independent
Description of dialysis prescription predictors of survival was tested using multiple logistic
regression with slope and most recent (that is, the sixth)In all patients, hemodialysis was performed using 1.8
m2 polysulfone (F80A; Fresenius USA, Concord, CA, concentration both included as candidate predictors.
Calculations were performed using SPSS for WindowsUSA) or, beginning in 1997, 2.1 m2 polymethylmethacry-
late (B1-2.1U; Toray Industries, Tokyo, Japan) hollow version 7.0 (SPSS Inc., Chicago, IL, USA).
fiber dialyzers (single-use) and Fresenius volumetric de-
livery systems with bicarbonate dialysate. The urea re-
RESULTS
duction ratio was measured at least once in 109 patients
Correlation among baseline characteristics(mean 3.7 determinations per patient); the mean was
and survival64 6 5%.
Initial serum albumin correlated inversely with base-
Statistical analysis line proteinuria (r 5 20.38, P , 1023) but was not associ-
ated with age (P , 0.68), diabetes (P , 0.22), or raceThe initial analysis explored the associations among
the baseline characteristics and their relationship to sur- (P , 0.71). Initial serum albumin was higher in patients
who survived the entire year than in patients who diedvival. Proportions were compared using the chi-square
test. Continuous variables are presented as the mean 6 during months 6 through 12 (P , 0.003; Fig. 1). Protein-
uria, however, did not differ significantly between survi-sd or, when stated, mean 6 se. Differences were tested
using the t-test for normally distributed variables or, vors and nonsurvivors (9.6 6 9.9 g/day vs. 6.8 6 6.0
g/day, P , 0.31 by Mann–Whitney U-test).when stated, the Mann–Whitney U-test for skewed distri-
butions. An association between continuous variables In contrast to albumin, the initial serum creatinine (at
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Table 1. Serial measurements of serum albumin and creatinine
Month Albumin (N) Creatinine (N)
1 3.3260.50 (115)
2 3.3860.52 (113) 8.02 63.25 (98)
3 3.4860.47 (109) 7.98 63.16 (96)
4 3.5660.51 (111) 8.22 63.34 (97)
5 3.6060.44 (109) 8.30 63.44 (94)
6 3.6960.48 (115) 8.37 63.45 (98)
7 8.5963.28 (99)
Units are g/dl for albumin and mg/dl for creatinine.
Table 2. Correlation of baseline proteinuria with monthly serum
albumin values
Month N r P
Fig. 1. Mean (6 SE) monthly serum albumin in 94 survivors (h) and 1 80 20.38 ,0.00121 nonsurvivors (j). The mean level was significantly higher in survivors 2 79 20.31 ,0.005
at month 1 (P , 0.003) and months 3 through 6 (P , 1023 for each 3 77 20.05 0.58
month) by t-test. 4 76 20.03 0.73
5 75 0.13 0.32
6 80 0.17 0.18
cantly from nonsurvivors in the other factors that influ-
enced creatinine: age (P , 0.50), diabetes (P , 0.79),
or race (P , 0.13).
Serum albumin trend
The monthly values of serum albumin showed a clearly
rising trend (Table 1), increasing by a mean of 13 6 21%
(P , 1029 vs. no change) from the first to the sixth
measurement (absolute values, 3.32 6 0.50 g/dl vs. 3.69 6
0.48 g/dl, P , 10210 by paired t-test). The inverse relation-
ship between baseline proteinuria and serum albumin,
noted earlier in this article, persisted in the second
month, but not in later months (Table 2).
Fig. 2. Mean (6 SE) monthly serum creatinine in 81 survivors (h) and The albumin trends differed in survivors and nonsurvi-18 nonsurvivors (j). The mean was significantly higher in survivors at
vors (Fig. 1). Overall, albumin rose by a mean 15%month 2 (P , 0.029), month 3 (P , 0.007), and months 4 through 7
(P , 1023 for each month) by t-test. in survivors (P , 1029 vs. no change) but only 4% in
nonsurvivors (15 6 21% vs. 4 6 21%, P , 0.036). A
repeat-measures analysis of variance model of the albu-
min values was constructed to further examine the inde-month 2) correlated independently with age (P , 1024),
pendent effects on serum albumin of survival status anddiabetes (P , 0.007), and race (P , 0.025) [multiple
of time modeled as a polynomial factor. Significant ef-linear regression equation, creatinine (mg/dl) 5 14.9 2
fects were found for survival status (P , 1025), time0.1 3 age 2 1.5 (if diabetic) 1 1.3 (if black); R 5 0.59,
(P , 0.030), and the interaction term, survival 3 timeP , 1028]. Similarly, urinary creatinine excretion corre-
(P , 0.046). Only the linear effects of time were highlylated inversely with age (r 5 20.34, P , 0.002) and
significant (linear effect of time, P , 1023; survival 3was somewhat higher in black patients (P , 0.07) and
linear effect of time, P , 0.009), consistent with differentnondiabetic patients (P , 0.09).
linear trends in survivors and nonsurvivors.Survivors had higher baseline creatinine excretion
The mean rate of rise (slope) of albumin for eachthan nonsurvivors (1018 6 457 mg/day vs. 754 6 364
patient (N 5 115) by linear regression was 0.08 6 0.12mg/day, P , 0.030). Initial serum creatinine correlated
g/dl/month (P , 1029 vs. zero slope). The slope did notdirectly with baseline creatinine excretion (r 5 0.32, P ,
correlate with age (P , 0.55), diabetes (P , 0.61), race0.007) and was also significantly higher in survivors than
(P , 0.54), or dialysis membrane (P , 0.27) but corre-in patients who died during months 7 through 12 (P ,
0.029; Fig. 2). However, survivors did not differ signifi- lated directly with baseline proteinuria (r 5 0.49, P ,
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Fig. 3. Rate of rise of serum albumin over six monthly measurements
plotted against baseline proteinuria (r 5 0.49, P , 1025). Symbols are:
(h) survivors; (j) nonsurvivors. Regression lines are shown separately
for each group: survivors (broken line; y 5 0.034 1 0.005x, r 5 0.50,
P , 1024), nonsurvivors (solid line; y 5 20.069 1 0.009x, r 5 0.45, P #
0.07). The two regression lines are significantly different in intercept
but not slope.
1025; Fig. 3). The correlation between albumin slope and
baseline proteinuria remained significant when exam-
ined separately in patients whose urine collection was
performed less than two months before initiating hemo-
dialysis (r 5 0.44, P , 0.003, N 5 43) or two months or
more before starting (r 5 0.55, P , 1023, N 5 37).
The slope of albumin versus time was higher in survi-
vors than in nonsurvivors (0.09 6 0.11 g/dl/month vs.
0.01 6 0.13 g/dl/month, P , 0.005). By multiple regres-
sion, the rate of rise of albumin was independently influ- Fig. 4. (A) Mortality during months 6 through 12 by the level of serum
enced by both proteinuria (P , 1025) and survival status albumin measured at the beginning of the sixth month (P , 1027 by
Mantel–Haenszel test for linear association). (B) Mortality during(P , 0.006) [slope 5 0.031 1 0.0056 3 proteinuria
months 6 through 12 by the rate of rise of serum albumin over the first(g/day) 2 0.074 3 survival status (survivor 5 0, nonsurvi- six monthly measurements (P , 0.022 by Mantel–Haenszel test for
vor 5 1), R 5 0.56, P , 1026]. For example, this equation linear association).
predicts that the rate of rise of serum albumin would be
approximately 0.06 g/dl/month for a survivor with 5 g of
proteinuria at baseline but only 0.03 g/dl/month for a tion was a significant independent predictor of mortality
survivor with no baseline proteinuria. (P , 0.002), but the slope was not (P , 0.41).
Both the individual albumin measurements and the
slope predicted mortality during the second half of the Serum creatinine trend
year, in univariate analysis (Figs. 1 and 4). A multiple The values of serum creatinine also showed a rising
logistic regression model was constructed to test whether trend (Table 1), increasing by a mean of 12 6 32% (P ,
the slope predicts mortality independently of the abso- 1023 vs. no change) between the second and seventh
lute value of serum albumin. Both the slope and the last months (absolute values, 8.02 6 3.25 mg/dl vs. 8.55 6
serum albumin were included in the model as mortality 3.28 mg/dl, N 5 98, P , 0.036 by paired t-test). The
predictors, and they were treated as categories as in direct correlation of baseline creatinine excretion with
Figure 4. [It should be noted that the sixth albumin and serum creatinine, noted earlier in this article, became
the slope are necessarily correlated with each other (r 5 stronger over time (Table 3).
0.52, P , 1025), a form of regression to the mean.] This Figure 2 shows mean monthly serum creatinine levels
in survivors and nonsurvivors. Between months 2 throughanalysis showed that the sixth serum albumin concentra-
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Table 3. Correlation of baseline creatinine excretion with monthly month in survivors, significantly different than zero (P ,
serum creatinine values
0.005), unlike the mean slope in nonsurvivors (20.07 6
Month N r P 0.48 mg/dl/month). However, the difference in mean
2 73 0.32 ,0.007 slope between survivors and nonsurvivors was of only
3 74 0.39 ,0.001 borderline significance (P , 0.059) by the t-test and
4 72 0.45 ,1024
became insignificant (P , 0.50) after adjusting for differ-5 69 0.49 ,1024
6 73 0.50 ,1024 ences in baseline creatinine excretion (P , 0.035) by
7 74 0.46 ,1024 multiple regression.
DISCUSSION
The mean serum albumin and creatinine have recently
been reported to rise in new hemodialysis patients [4,
14]. The magnitude of these trends, however, may be
exaggerated by the continuous attrition of patients with
low albumin and creatinine levels from the cohorts stud-
ied. Additionally, although the rise in serum creatinine
is probably the result of a concurrent fall in renal function
[12, 18, 19], the basis for the rise in albumin is unknown.
This study, for the first time to our knowledge, quantifies
the rates of rise of serum albumin and creatinine in a
cohort of stable hemodialysis patients over the first half
year of dialysis, and examines the relationship of these
rates to baseline clinical factors, including urinary pro-
tein and creatinine excretion, and to subsequent survival.
The analysis was performed on a pre-existing, prospec-
tively collected patient registry and serum biochemistry
database. Urinary data were examined retrospectively,
Fig. 5. Rate of rise of serum creatinine over six monthly measurements and although they were available in most but not all
plotted against baseline urinary creatinine excretion (r 5 0.26 P , 0.025).
patients, there were no obvious differences between pa-Different symbols are used for survivors (h) and nonsurvivors (j).
Regression lines are shown separately for each group: survivors (- - - -; tients with and without such data. All patients were dia-
y 5 20.425 1 0.207x, r 5 0.21, P , 0.11), nonsurvivors (———; y 5 lyzed with high-flux biocompatible membranes, thereby
20.289 1 0.391x, r 5 0.45, P , 0.11). The two regression lines are not
avoiding potential confounding by an effect of the dial-significantly different in slope or intercept.
ysis membrane [14].
Serum albumin rose by a mean rate of 0.08 g/dl/month,
with a mean relative rise of 13% from the first to the
7, serum creatinine rose by a mean of 14% in survivors sixth measurement. The rate was not correlated with
(P , 1023 vs. no change) but only 1% in nonsurvivors age, diabetes, or race. If, as we hypothesized, the rise in
(14 6 31% vs. 1 6 35%, P , 0.13). Further examining serum albumin were the result of declining residual renal
the effects of survival status and time on serum creatinine protein losses, analogous to remission of the nephrotic
using repeat-measures ANOVA showed a significant in- syndrome [17], there would be several expected effects:
teraction between survival status and the linear effect (a) The amount of predialysis urinary protein loss should
of time (P , 0.05). This is consistent with significantly be a predictor of the serum albumin level in new hemodi-
different linear trends in survivors and nonsurvivors. alysis patients, but (b) its influence should decline during
The mean rate of rise of serum creatinine for each the initial half year as the protein loss itself declines.
patient (N 5 99) by linear regression was 0.12 6 0.47 Consistent with these predictions, baseline proteinuria
mg/dl/month (P , 0.013 vs. zero slope). The slope of correlated inversely with initial serum albumin (r 5
serum creatinine versus time did not correlate with age 20.38 P , 1023) and directly with the albumin slope
(P , 0.64), diabetes (P , 0.12), race (P , 0.92), or (r 5 0.49 P , 1025), and the inverse association between
membrane type (P , 0.37), but did correlate directly baseline proteinuria and serum albumin progressively
with baseline urine creatinine excretion (r 5 0.26, P , weakened with time (Table 2). The strength of the in-
0.025; Fig. 5). This correlation remained significant (par- verse correlation we observed between initial serum al-
tial r 5 0.29, P , 0.015), even after adjusting for age, bumin and baseline urinary protein loss is similar to that
diabetes, and race. observed in patients with nephrotic syndrome [37, 38].
The direct correlation observed between proteinuria andThe mean creatinine slope was 0.16 6 0.47 mg/dl/
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the albumin rise suggests that patients with the most correlated directly with mortality risk in hemodialysis
patients.severe proteinuria at baseline were affected the most by
a subsequent decline in their proteinuria after dialysis Both the individual albumin measurements and the
slope were correlated with survival during the secondwas initiated and, therefore, are most likely to have their
mortality risk overestimated by using the level of serum half of the year (Figs. 1 and 4). For two patients with
the same current value of serum albumin, a clinicianalbumin at the first month. Surprisingly, the rate of de-
cline of proteinuria in new hemodialysis patients has not might expect that the patient whose concentration had
been rising faster would have the better prognosis. How-been reported. It was not examined in our group because
urine data were not available after the initiation of hemo- ever, by multiple logistic regression, the slope did not
add significant information to an estimate of prognosisdialysis.
Another implication of the hypothesis concerns such based on serum albumin alone.
Serum creatinine and baseline creatinine excretion“nutritional” markers as serum cholesterol and prealbu-
min that, in contrast to serum albumin, are elevated by correlated directly. The correlation actually became
stronger with time (Table 3), presumably because of thethe nephrotic state (abstract; Maru et al, J Am Soc
Nephrol 8:72A, 1997) [37–40]. As residual proteinuria progressive increase in the fraction of the daily creatinine
load appearing in serum as renal function declined. Se-declines, it might be expected that the levels of choles-
terol and prealbumin would not increase to the same rum creatinine was also higher in younger patients, non-
diabetics, and blacks, as in other studies [2, 42, 43]. Thesedegree as albumin or might even decline as proteinuria
falls over this period. Although neither of these markers group differences in the serum level are probably due
to differences in creatinine generation, consistent withwas routinely measured in our patients, the study of
Parker et al did not detect a rising trend for prealbumin the differences in urinary creatinine excretion observed
in this study and others [44, 45] (A. Levey, personaldespite a significant rise in albumin [14].
Survivors with no baseline proteinuria also demon- communication [46]). Creatinine excretion, in turn,
largely reflects variation in somatic protein status, orstrated a rise in serum albumin, albeit at a slower rate
(0.03 g/dl/month by the multiple linear regression model muscle mass. Lesser influences include the dietary intake
of creatine and protein and creatininase activity by intes-vs. 0.06 g/dl/month for survivors with 5 g proteinuria per
day). This implies that part of the increase in albumin tinal bacteria [22, 47].
Serum creatinine rose by a mean of 0.12 mg/dl/monthis independent of declining proteinuria and that other
factors, such as increased synthesis, decreased catabo- between the second and seventh months, with a mean
relative rise of 12% over the entire half-year period. Alism, hemoconcentration and/or lower transcapillary es-
cape (reviewed earlier in this article), must also contrib- rise in serum creatinine is expected as residual renal
creatinine clearance declines, and a greater absolute butute. Further studies are needed to prospectively test the
relationship over time between serum albumin and resid- not relative rise in serum creatinine would be expected
in patients with higher creatinine generation. Consistentual proteinuria, as well as to examine the role of other
time-dependent variables such as dietary intake, acidosis, with this expectation, baseline creatinine excretion cor-
related directly with the slope of serum creatinine versuslevels of inflammatory markers, membrane type, dialytic
loss of amino acids, and state of hydration. time (Fig. 5). Therefore, as was noted for albumin, pa-
tients with the highest creatinine appearance rate at base-Despite the initiation of dialysis and the presumed
decline in proteinuria, the group that failed to survive the line tend to have the fastest rate of rise of serum creati-
nine after initiating dialysis and, therefore, are mostsecond half of the year did not demonstrate a significant
mean rise in serum albumin over time (0.01 g/dl/month, likely to have their mortality risk overestimated by using
the level of serum creatinine measured at an early month.P 5 NS, in contrast to a significant rise of 0.09 g/dl/
month observed in survivors, P , 10220). This difference Baseline urinary creatinine excretion also correlated
with survival during months 6 through 12 (P , 0.03), aimplies that the determinants of serum albumin differ
between the two groups. Either dietary intake is poor novel observation supporting the idea that baseline mus-
cle mass is a predictor of survival on dialysis. In anor fails to improve in nonsurvivors; the residual renal
protein losses of nonsurvivors persist longer, or other analogous finding, the creatinine generation rate in he-
modialysis patients, calculated by kinetic modeling, hasfactors are present in nonsurvivors that prevent the albu-
min rise. One such factor could be increased levels of been reported to correlate with survival [48]. Survivors
also had higher initial values for serum creatinine (P ,proinflammatory cytokines, such as interleukin-1b, in-
terleukin-6, and tumor necrosis factor-a, which can de- 0.03), a well-established association [1–5]. Given the
higher rate of generation of creatinine of survivors be-press the synthesis of albumin and/or increase its trans-
capillary escape [3, 9]. Levels of these cytokines have fore starting dialysis and their presumed lower preva-
lence of wasting illness, one might expect them to havebeen reported to be elevated in uremic patients [8, 9],
and in one report [41], the serum interleukin-6 level a faster rate of rise in serum creatinine after initiating
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Table 4. Factors that could influence creatinine trend in Death on Hemodialysis, edited by Friedman EA, Netherlands,
Kluwer, 1994, pp 121–141
Renal and nutritional factors 2. Lowrie EG, Lew NL, Huang WH: Race and diabetes as death
Decline in residual renal creatinine excretion risk predictors in hemodialysis patients. Kidney Int 42(Suppl
Increased intake of creatine-containing foods (meat) 38):S22–S31, 1992
Increase in muscle mass (e.g., due to use of androgens, or to exercise 3. Goldwasser P, Feldman J: Association of serum albumin and
enabled by increased hematocrit and use of rocaltrol, or to mortality risk. J Clin Epidemiol 50:693–703, 1997
decreased muscle catabolism with better control of acidosis) 4. Culp K, Flanigan M, Lowrie EG, Lew N, Zimmerman B: Model-
ing mortality risk in hemodialysis patients using laboratory valuesDialysis-related factors
as time-dependent covariates. Am J Kidney Dis 5:741–746, 1996Switch from dialysis twice a week to dialysis three times a week as
5. Bloembergen WE, Stannard DC, Port FK, Wolfe RA, Pughaccess matures or as residual function declines
JA, Jones CA, Greer JW, Golper TA, Held PJ: RelationshipModification of dialysis prescription by clinician
of dose of hemodialysis and cause-specific mortality. Kidney IntFluctuations in patient attendance
50:557–565, 1996
Other factors 6. Grodstein GP, Blumenkrantz MJ, Kopple JD: Nutritional and
Amputation metabolic responses to catabolic stress in uremia. Am J Clin Nutr
Wasting illness 33:1141–1416, 1980
Antibiotics (decreased bacterial creatininase activity) 7. Reaich D, Price SR, England BK, Mitch WE: Mechanisms caus-
Drugs that impair creatinine secretion (trimethoprim, cimetidine) ing muscle loss in chronic renal failure. Am J Kidney Dis 26:242–
247, 1995
8. Guarnieri G, Toigo G, Fiotti N, Ciocchi B, Situlin R, Giansante
C, Vasile A, Carraro M, Faccini L, Biolo G: Mechanisms of
malnutrition in uremia. Kidney Int 52(Suppl 62):S41–S44, 1997
9. Kaizu Y, Kimura M, Yoneyama T, Miyaji K, Hibi I, Kumagai H:dialysis. In fact, a large difference was observed, although
Interleukin-6 may mediate malnutrition in chronic hemodialysisof only borderline significance (0.16 vs. 20.07 mg/dl/
patients. Am J Kidney Dis 31:93–100, 1998
month, P , 0.06). In any event, adjusting for differences 10. Avram M, Goldwasser P, Derkatz D, Gusik S-A: Correlates of
long-term survival on hemodialysis, in Death on Hemodialysis,in baseline creatinine excretion eliminated any signifi-
edited by Friedman EA, Netherlands, Kluwer, 1994, pp 169–176cance of this difference (P , 0.50), implying that the 11. Jones CH, Newstead CG, Wills EJ, Davison AM: Serum albumin
higher mean creatinine slope in survivors was most likely and survival in CAPD patients: The implications of concentration
trends over time. Nephrol Dial Transplant 12:554–558, 1997due to their greater daily creatinine load. There are many
12. Hiroshige K, Yuu K, Soejima M, Takasugi M, Kuroiwa A: Rapidclinical, time-dependent factors (Table 4) that could have decline of residual renal function in patients on automated perito-
contributed to the variation in serum creatinine over neal dialysis. Perit Dial Int 16:307–315, 1996
13. Young GA, Taylor A, Kendall S, Brownjohn AM: Longitudinaltime. Future studies are needed to examine prospectively
study of proteins in plasma and dialysate during continuous ambu-
the complex relationship over time between serum creat- latory peritoneal dialysis. Perit Dial Int 10:257–261, 1990
14. Parker TF III, Wingard RL, Ikizler TA, Parker RA, Hakiminine and these factors.
RM: Effect of membrane bioincompatibility on nutritional parame-In summary, serum albumin and creatinine levels rose
ters in chronic hemodialysis patients. Kidney Int 49:551–556, 1996
by 12 to 13% during the first half year of hemodialysis 15. Locatelli F, Mastrangelo F, Redaelli B, Ronco C, Marcelli
D, La Greca G, Orlandini G, the Italian Cooperative Dialysisin a stable cohort. The mean rate of rise in serum albumin
Study Group: Effects of different membranes and dialysis technol-was significantly higher in survivors than nonsurvivors,
ogies on patient treatment tolerance and nutritional parameters.
but the rate was not as predictive as the absolute level Kidney Int 50:1293–1302, 1996
16. Ross EA, Koo LC: Improved nutrition after the detection andof serum albumin. Although the rate of rise of serum
treatment of occult gastroparesis in nondiabetic dialysis patients.creatinine was only marginally higher in survivors, the
Am J Kidney Dis 31:62–66, 1998
mean serum creatinine and baseline urinary creatinine 17. Goldwasser P: Albumin trend and mortality. (letter) Am J Kidney
Dis 30:308, 1997values were significantly higher than in nonsurvivors.
18. Lameire NH: The impact of residual renal function on the adequacyThe pattern of correlations of baseline urinary protein of peritoneal dialysis. Nephron 77:13–28, 1997
and creatinine with the respective monthly serum values 19. Hartmann J, Fricke H, Schiffl H: Biocompatible membranes
preserve residual function in patients undergoing regular hemodi-of albumin and creatinine and their slopes is consistent
alysis. Am J Kidney Dis 30:366–373, 1997with the hypothesis that as residual renal excretion de- 20. Heymsfield SB, Arteaga C, McManus C, Smith J, Moffitt S:
clines in new dialysis patients, the progressive retention Measurement of muscle mass in humans: Validity of the 24-hour
creatinine method. Am J Clin Nutr 37:478–494, 1983of protein and creatinine contributes to the respective
21. Kaysen GA, Rathore V, Shearer GC, Depner TA: Mechanismsrises in serum albumin and creatinine. These findings of hypoalbuminemia in hemodialysis patients. Kidney Int 48:510–
add to our growing understanding of the importance of 516, 1995
22. Bergstro¨m J, Heimbu¨rger O, Lindholm B, Qureshi AR: Elevatedresidual renal function in the dialysis patient.
C-reactive protein is a strong predictor of increased mortality and
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